chr14-67656583-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_006370.3(VTI1B):c.373C>A(p.Leu125Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000143 in 1,599,748 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_006370.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
VTI1B | NM_006370.3 | c.373C>A | p.Leu125Ile | missense_variant | 4/6 | ENST00000554659.6 | |
GPHN | XM_047430879.1 | c.1313-78612G>T | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
VTI1B | ENST00000554659.6 | c.373C>A | p.Leu125Ile | missense_variant | 4/6 | 1 | NM_006370.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000657 AC: 100AN: 152202Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000199 AC: 48AN: 240742Hom.: 0 AF XY: 0.000184 AC XY: 24AN XY: 130584
GnomAD4 exome AF: 0.0000891 AC: 129AN: 1447428Hom.: 0 Cov.: 30 AF XY: 0.0000972 AC XY: 70AN XY: 720152
GnomAD4 genome AF: 0.000657 AC: 100AN: 152320Hom.: 0 Cov.: 32 AF XY: 0.000510 AC XY: 38AN XY: 74484
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 12, 2021 | The c.373C>A (p.L125I) alteration is located in exon 4 (coding exon 4) of the VTI1B gene. This alteration results from a C to A substitution at nucleotide position 373, causing the leucine (L) at amino acid position 125 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at